NPPES file of Aug 9, 2026

Marika-Foteni Antimisiaris, MD

Epilepsy Physician · Louisville, KY

Marika-Foteni Antimisiaris, MD is an epilepsy physician with a practice address in Louisville, Kentucky, and NPI 1497286348, issued on Mar 22, 2017. Check the license (Kentucky 60584, as entered in NPPES) on the Kentucky Board of Medical Licensure; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1497286348
Name
Marika-Foteni Antimisiaris
Credential
MD
Primary taxonomy
Epilepsy Physician 2084E0001X
License numbers
60584 KY
01096482A IN
332417 LA
Self-reported in NPPES; status is on the state search
Practice location
4915 Norton Healthcare Blvd Ste 301, Louisville, KY 40241
Phone
(502) 394-6460
Enumerated
Mar 22, 2017
Record last updated
Aug 19, 2025
Fax
(502) 394-6465
Medicare enrollment
Enrolled (PECOS I20221003003067); accepts Medicare assignment
Medical or professional school
University Of Louisville School Of Medicine, 2017
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 4915 Norton Healthcare Blvd Ste 301

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Stephanie Alsorogi, APRNFamily Nurse Practitioner1164887576
  2. Nathaniel Beachy, M.D.Clinical Neurophysiology Physician1992238646
  3. Rabia Buridi, MDVascular Neurology Physician1710482443
  4. Tamika Burrus, MDVascular Neurology Physician1447457353
  5. Jessica Cain, PAPhysician Assistant1740664283
  6. Richard ChapmanPhysician Assistant1518755412

Verify Marika-Foteni Antimisiaris in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersKentucky Board of Medical Licensure
    Search for license 60584
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Kentucky license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

70% more Medicare Part D claims than the average epilepsy physician in 2024

1,591 Medicare Part D claims for 256 beneficiaries, against an average of 934 among the 476 providers of this specialty who prescribed in Part D. Brand-name drugs were 13% of claims.

  1. Marika-Foteni Antimisiaris1,591
  2. Specialty average934

Most prescribed

  1. Levetiracetam285 claims
  2. Lacosamide148 claims
  3. Lamotrigine80 claims
  4. Clonazepam77 claims
  5. Gabapentin65 claims
  6. Clobazam62 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Industry payments in 2024: $979.28

32 payments; by number, the most common kind was food and beverage; the largest payer was Ucb, Inc. The 345 providers of this specialty with any payment received $6,278.39 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Marika-Foteni Antimisiaris$979.28
  2. Specialty average$6,278.39

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through 2 group practices

  1. Community Medical Associates IncClarksville, IN
  2. Ochsner Clinic LLCNew Orleans, LA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Epilepsy Physician providers in Kentucky

There are 4 epilepsy physician records in Kentucky.

The 3 epilepsy physician records with the nearest ZIP codes

  1. Cemal Karakas, M.DLouisville, KY 402021831550243
  2. Barbara Kwiecinska, MDLouisville, KY 402021821626300
  3. Marjan Asadollahi, MDLexington, KY 405361669155503

Common questions

What is Marika-Foteni Antimisiaris, MD's NPI number?

Marika-Foteni Antimisiaris, MD's National Provider Identifier (NPI) is 1497286348, issued on Mar 22, 2017. An NPI identifies a provider in billing; it is not a license.

Where is Marika-Foteni Antimisiaris, MD located?

The NPPES record lists a practice address at 4915 Norton Healthcare Blvd Ste 301, Louisville, KY, 40241. Phone: (502) 394-6460. Providers update this record themselves, so call before visiting.

How can I verify Marika-Foteni Antimisiaris, MD's license?

NPPES lists Kentucky license number 60584, as entered by the provider. Search the Kentucky Board of Medical Licensure at https://web1.ky.gov/GenSearch/LicenseSearch.aspx?AGY=5. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Marika-Foteni Antimisiaris, MD prescribe under Medicare Part D?

In 2024, Marika-Foteni Antimisiaris, MD had 1,591 Medicare Part D claims for 256 beneficiaries; the average among epilepsy physician prescribers was 934. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.